• BMS at ESMO 2020

    ?Continuing our pursuit of scientific advancement for people with?cancer

    Intended for U.S. scientific audiences only.
    T

    he European Society for Medical Oncology (ESMO)?annual meeting is a critical hub for scientific exchange, and despite the challenges of the past year, our commitment to collaborating with the community and pursuing innovative solutions for patients with cancer remains steadfast. We look forward to exploring the latest research approaches and sharing progress for people affected by cancer.

    Driving Innovation Through Collaboration?

    Hear from our chief medical officer of Global Drug Development, Samit Hirawat, M.D., about our commitment to working together to transform outcomes for people with cancer.?

    ?Our Data at ESMO

    Read more about our key data being presented at the meeting.

    Our Science???

    We are working every day to develop innovative therapies for people affected by cancer. Learn about our recent advances and what we have on the horizon.

    Addressing Cancer Earlier?

    We are researching the role immunotherapy may play in improving patient outcomes when used?in?earlier?stages of a patient’s disease.?Hear more from our development lead of Gastrointestinal Cancers, Ian Waxman, M.D.

    Approaching Thoracic Cancers from Different Angles

    Approaching Thoracic Cancers from Different Angles??

    The needs of patients with lung cancer are unique, which is why we’re exploring a variety of treatment approaches.?Learn from our vice president and head of Oncology Clinical Development, Sabine Maier, M.D.

    In the Pipeline

    In the Pipeline?

    What pathways are we researching in oncology and hematology? Visit our?R&D pipeline?page to find out.?

    Advancing Cancer Research: Yesterday, Today and Tomorrow

    Advancing Cancer Research: Yesterday, Today and Tomorrow?

    Learn about advancements in cancer research throughout history and how they lead to where we are today.?

    Cell Therapy

    Cell Therapy?

    Learn more about the science behind cell therapy.?

    Comprehensive Approach to Cancer Research

    Comprehensive Approach to Cancer Research?

    Learn about our comprehensive approach to cancer research across the biological spectrum, exploring various modalities, research approaches and important areas of focus.??

    Continuing Oncology Advancements During COVID-19

    The work done by the entire medical community inspires us to do our part for people living with cancer every day, but especially during these challenging and unpredictable times.

    COVID Advocacy Exchange Insights

    Partnering to Improve Cancer Care in the Age of COVID-19

    Leaders from BMS and the oncology advocacy community discuss the immediate and long-term impacts for cancer patients as a result of the COVID-19 pandemic.

    Addressing Barriers to Clinical Trial Participation and Clinical Trial Diversity

    Addressing Barriers to Clinical Trial Participation and Clinical Trial Diversity?

    A conversation with our chief medical officer of Global Drug Development, Samit Hirawat, M.D.

    Supporting the Evolving Needs of People Living with Blood Cancer?

    Learn more about BMS’ commitment to people living with blood cancer?from our vice president of Hematology Global Medical Affairs, Diane McDowell, M.D.

    Resources

    Our research at ESMO this year spans 15 different types of cancer and multiple therapeutic modalities. Learn more about some of them below.

    Protein Degradation?Fact?Sheet?

    Understand the process of cellular protein degradation.?

    LSD1 Pathway Fact Sheet??

    Learn more about the LSD1 pathway and its implications in cancer research.

    Disease State Infographics??

    Download infographic?resources?on different cancers and disease types.?

    欧美A级V片